United Laboratories International Holdings Ltd., Theの希薄化後一株あたり利益推移
(単位:百万) | 希薄化後一株あたり利益 | 前年比 |
---|
Sale of intermediate products, sale of bulk medicine and sale of antibiotics finished products, non-antibiotics finished products and capsule casings.
Sale of intermediate products, sale of bulk medicine and sale of antibiotics finished products, non-antibiotics finished products and capsule casings.